MR

Mohammad Rafeeq

Active Director Director DIN 08120574
DIN 08120574 First appointment Apr 2018 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Mohammad Rafeeq

Data last updated:

Mohammad Rafeeq is a Director at Creature Pharma Private Limited (since 2018). The company operates in Food And Beverages. Creature Pharma Private Limited reported revenue of ₹17,200 (FY 2020).

DIN 08120574
Primary Designation Director
Industry Food And Beverages
First Appointment 26 Apr 2018
Oldest Company Age 8 yrs
Largest company Creature Pharma Private Limited · ₹17,200 (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Creature Pharma Private Limited U24304UP2017PTC099081
Director26 Apr 20182017₹17,200 (FY 2020)Active

Board colleagues of Mohammad Rafeeq

Directorship timeline

Open interactive timeline →
Creature Pharma Private Limited
Premium access

Shareholding and investment profile for Mohammad Rafeeq

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammad Rafeeq

Mohammad Rafeeq currently holds 1 directorship: Creature Pharma Private Limited (Director, since 26 Apr 2018, revenue ₹17,200 (FY 2020)).

Mohammad Rafeeq was first appointed on 26 Apr 2018 as Director at Creature Pharma Private Limited.

The current boards of Mohammad Rafeeq's companies include Adarsh Kumar Pathak (Creature Pharma Private Limited), Prafull Kumar Mishra (Creature Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available